Pentagalloyl glucose targets the JAK1/JAK3-STAT3 pathway to inhibit cancer stem cells and epithelial–mesenchymal transition in 5-fluorouracil-resistant colorectal cancer
Open Access
- 17 April 2025
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 142, 156773
Abstract
No abstract availableKeywords
Funding Information
- Sichuan Provincial Science and Technology Support Program (2022YFS0626)
- Southwest Medical University
This publication has 41 references indexed in Scilit:
- Intricate relationship between cancer stemness, metastasis, and drug resistanceMedcomm, 2024
- Revisiting Luteolin Against the Mediators of Human Metastatic Colorectal Carcinoma: A Biomolecular ApproachJournal of Cellular Biochemistry, 2024
- Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axisMolecular Therapy-Oncolytics, 2021
- Role of STAT3 signaling transduction pathways in cancer stem cell-associated chemoresistanceDrug Discovery Today, 2021
- 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibitionBiomedicine & Pharmacotherapy, 2021
- 3D chromatin architecture and epigenetic regulation in cancer stem cellsProtein & Cell, 2021
- Cancer stem cell (CSC) resistance driversLife Sciences, 2019
- Maprang “Bouea macrophylla Griffith” seeds: proximate composition, HPLC fingerprint, and antioxidation, anticancer and antimicrobial properties of ethanolic seed extractsHeliyon, 2019
- Pentagalloyl Glucose and Its Functional Role in Vascular Health: Biomechanics and Drug-Delivery CharacteristicsAnnals of Biomedical Engineering, 2018
- EMT: Mechanisms and therapeutic implicationsPharmacology & Therapeutics, 2018